A study into a weight-loss drug which could reduce heart attacks appears on several front pages on Tuesday.

Trials of a weight-loss drug which could cut the risk of heart attacks and strokes by a fifth feature heavily as a range of stories compete for attention on Tuesday’s newspaper front pages.

The Times reports that the biggest study of semaglitude – known as Ozempic or Wegovy – could pave the way for millions of middle-aged patients to receive injections.

The jabs are labelled a “game-changer” by the Daily Mail, a line echoed in the Daily Express which says the drug could cut weight and save lives.

The study also appears on the front of The Daily Telegraph, which leads on the arrest of three people accused of spying on Hong Kong dissidents in the UK.

The Independent concentrates on the Prime Minister’s pitch to voters, saying he has pushed the “nuclear general election button”, while The Guardian looks at a Labour report calling for action on rent amid a growing housing crisis.

The whole political spectrum comes under fire on the front of the i, which says all parties are failing save British wildlife.

The Metro turns its attention to royal matters with the King revealing he has lost his sense of taste during cancer treatment.

The families of Manchester United players have been told to make their own way to Wembley for the FA Cup final, according to the Daily Mirror.

The Financial Times concentrates on Anglo American rejecting an improved takeover proposal from BHP.

And the Daily Star reports on former US president Donald Trump labelling fictional cannibal Hannibal Lecter “a wonderful man”.

More from Perspective

Get a free copy of our print edition

News

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Your email address will not be published. The views expressed in the comments below are not those of Perspective. We encourage healthy debate, but racist, misogynistic, homophobic and other types of hateful comments will not be published.